Hepatitis Diagnostic Test Market - Global industry Analysis, Size, Share, Growth, Trends and Forecast 2018 - 2028
Hepatitis Diagnostic Test Market: Overview
The global hepatitis diagnostic test market is prognosticated to witness a surge in its demand during the forecast period 2018-2028. The rising incidence of hepatitis A, B, and C in comparison to D and E, in the last decade, has fuelled the demand for hepatitis diagnostic tests around the world. Hepatitis is a medical condition in which the liver swells up, leading to other types of complications such as liver failure, anorexia, cirrhosis, and jaundice. It has been observed that nearly 300 million people across the world are infected to any one form of hepatitis, thus pushing the need for hepatitis diagnostic test in various parts of the country. According to the World Health Organization, nearly 500,000 people die on a yearly basis due to hepatitis. The increasing awareness about the disease and its symptoms will fuel the demand for hepatitis diagnostic tests.
The global hepatitis diagnostics test market is likely to expand at 6.5% CAGR during the forecast period. According to TMR Research, the market is likely to reach US$6.9 bn by the end of 2028.
Hepatitis Diagnostic Test Market: Trends and Opportunities
Various bodies such as government, non-profitable organizations, and NGOs, play an important role in the global hepatitis diagnostic test market. These bodies help in creating awareness about various medical conditions by providing correct information associated to the symptoms and detection techniques. Rise in awareness regarding the disease positively impacts the market. Apart from these, technological advancements such as molecular diagnostics comprising RNA and DNA testing are promoting the market growth.
However, it has been noticed that the prevalence of hepatitis type B and C is excessively high in countries with middle-income and low income. A few of the African and Asian countries do fall in this category. Lack of skilled labors accompanied with high cost for test is likely to hinder the market’s growth in the future. Techniques such as PCR, CLIA, ELISA, and RIBA which are used to perform immunoassays are not cheap, which makes them expensive for patients and their families in underdeveloped countries. This may restrict the market’s trajectory to an extent. Nevertheless, liver function tests which are the first line detection for this disease is likely to push the market during the assessed period.
Global Hepatitis Diagnostic Test Market: Market Potential
Recently, the US Food and Drug Administration has given a nod to a pair of assays which are designated for the use with an immunodiagnostic system which is known to spot HBV in individuals. These move has offered the physicians and patients of consolidating all their test onto Ortho’s VITROSs system. This is likely to make consumers more aware about the disease in future.
Global Hepatitis Diagnostics Test Market: Regional Outlook
On the basis of geography, North America held the largest share in terms of revenue in 2016. Early adoption of advanced technologies and high level of awareness among consumers about novel therapeutics and diagnostic tests is contributing to the growth of market in the region. Initiatives by non-government and government organizations in Canada are also contributing to the growth of the market in the region. For example, The Public Health Agency of Canada conducted the World Hepatitis Day for creating awareness regarding hepatitis detection, this has positively impacted the demand for hepatitis diagnostic tests in the country. It is predicted that Asia Pacific is going to witness a surge in demand for detection techniques in the coming years.
Global Hepatitis Diagnostics Test Market: Competitive Landscape
There are few players in the market who are dominating the market through strategic partnership and acquisitions with regional or local players in an aim to expand their footprints in various regions. Major players in the market are Abbott Laboratories, MedMira, Inc., Danaher Corporation, Bio Rad Laboratories, and DiaSorin S.p. A.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report